Napredna pretraga

Pregled bibliografske jedinice broj: 388124

Continuous glucose monitoring system based on microdialysis in assessment of glycaemia in type 2 diabetic microalbuminuric patients – a pilot study


Eržen Jurišić, Dubravka; Radman, Maja; Ljutić, Dragan; Glavaš, Duška; Kovačić, Nataša
Continuous glucose monitoring system based on microdialysis in assessment of glycaemia in type 2 diabetic microalbuminuric patients – a pilot study // Book of Abstracts WCN 2007
Rio de janeiro, Brasil, 2007. (poster, međunarodna recenzija, sažetak, stručni)


Naslov
Continuous glucose monitoring system based on microdialysis in assessment of glycaemia in type 2 diabetic microalbuminuric patients – a pilot study

Autori
Eržen Jurišić, Dubravka ; Radman, Maja ; Ljutić, Dragan ; Glavaš, Duška ; Kovačić, Nataša

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni

Izvornik
Book of Abstracts WCN 2007 / - , 2007

Skup
World congress of nephrology 2007

Mjesto i datum
Rio de janeiro, Brasil, 21-25.04.2007

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Continuous glucose monitoring; diabetic nephropathy

Sažetak
Background and Aims:The progression of diabetic nephropathy is related to the degree of glycemic control. We used the continuous glucose monitoring system based on microdialysis (GlucoDay, A.Menarini) to evaluate blood glucose excursions in microalbuminuric type 2 diabetic patients. Patients and methods: Fifty type 2 diabetic and microalbuminuric ( rate of albumin excretion 20-199 ug/min) patients on two times/day NPH insulin and before meals three times/day lispro insulin were enrolled in our pilot study. Their characteristics were as follows: 24 male, 26 female, mean age 65 years, diabetes duration 9, 8 +3, 2 years, mean HbA1c was 8, 33 % + 1, 08 %. A 48 hours monitoring was obtained to all patients on the beginning and after 3 months observation period. The information was downloaded and analysed retrospectively by a diabetologist. Results: At baseline, time spent in the euglycemic range (glucose between 3.9 and 8.0 mmol/l) was 46, 87 &plusmn ; 10, 22 %. At end point, time in the euglycemic range increased on 62, 37 &plusmn ; 12, 20 %. Time spent in the hypoglycemic range (glucose below 3.9 mmol/l) was 9.23 &plusmn ; 2.83 % at baseline. At end point, time in the hypoglycemic range decreased 6.6 &plusmn ; 1.68 %. HbA1c was significantly improved from the value 8.33 &plusmn ; 1.08 % observed at the beginning to 7.64 &plusmn ; 0, 92 % after 3 months. Conclusions: This pilot study suggested that continuous glucose monitoring offers to diabetics and diabetologists more informations about glucose excursions and influences on achieving better metabolic control.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekt / tema
062-0620529-0517 - Regeneracija mozga, perifernog živca i skeletnog mišića u šećernoj bolesti (Romana Jerković, )

Ustanove
Klinički bolnički centar Rijeka